These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 883553)

  • 1. Action of beta(4-chlorphenyl)GABA, gamma-hydroxybutyrolactone, and apomorphine on central dopamine neurons.
    Fuxe K; Agnati L; Everitt BJ; Hökfelt T; Ljungdahl A; Perez de la Mora M
    Adv Biochem Psychopharmacol; 1977; 16():489-94. PubMed ID: 883553
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance to the effects of baclofen and gamma-butyrolactone on locomotor activity and dopaminergic neurons in the mouse.
    Gianutsos G; Moore KE
    J Pharmacol Exp Ther; 1978 Dec; 207(3):859-69. PubMed ID: 731436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.
    Gianutsos G; Thornburg JE; Moore KE
    Psychopharmacology (Berl); 1976 Nov; 50(3):225-9. PubMed ID: 826966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Butyrolactone effects on behavior induced by dopamine agonists.
    Ellinwood EH; Gonzalez AE; Dougherty GG
    Biol Psychiatry; 1983 Sep; 18(9):1023-32. PubMed ID: 6685535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
    Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover.
    Fuxe K; Agnati LF; Corrodi H; Everitt BJ; Hökfelt T; Löfström A; Ungerstedt U
    Adv Neurol; 1975; 9():223-42. PubMed ID: 1146654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():495-9. PubMed ID: 18898
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists.
    Kalivas PW; Duffy P; Eberhardt H
    J Pharmacol Exp Ther; 1990 May; 253(2):858-66. PubMed ID: 2160011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the mesocortical dopamine neurons.
    Fuxe K; Hökfelt T; Agnati L; Johansson O; Ljungdahl A; Perez de la Mora M
    Adv Biochem Psychopharmacol; 1977; 16():47-55. PubMed ID: 883552
    [No Abstract]   [Full Text] [Related]  

  • 10. Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen.
    Mereu G; Muntoni F; Calabresi P; Romani F; Boi V; Gessa GL
    Neurosci Lett; 1986 Apr; 65(2):161-6. PubMed ID: 3714103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of GABA and GABA-like drugs on monoaminergic mechanisms.
    Carlsson A; Biswas B; Lindqvist M
    Adv Biochem Psychopharmacol; 1977; 16():471-5. PubMed ID: 302084
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonstriatal dopaminergic neurons: role of presynaptic receptors in the modulation of transmitter synthesis.
    Roth RH; Nowycky MC
    Adv Biochem Psychopharmacol; 1977; 16():465-70. PubMed ID: 18895
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of dopaminergic agents on the serotoninergic neurons.
    Maj J
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):45-6. PubMed ID: 1208231
    [No Abstract]   [Full Text] [Related]  

  • 14. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine.
    Bioulac B; Fumoux F; Ferron A; Vincent JD
    Eur J Pharmacol; 1978 Sep; 51(1):29-37. PubMed ID: 699972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gamma-Hydroxybutyrate: effects on nonstriatal dopaminergic neurons.
    Roth RH; Nowycky MC; Walters JR; Morgenroth VH
    Adv Biochem Psychopharmacol; 1977; 16():483-8. PubMed ID: 18897
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisecond oscillations in the subthalamic nucleus: effects of apomorphine and dopamine cell lesion.
    Allers KA; Kreiss DS; Walters JR
    Synapse; 2000 Oct; 38(1):38-50. PubMed ID: 10941139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity of the climbing behaviour response to apomorphine induced by a short depression of dopaminergic neurone activity.
    Marcais H; Protais P; Costentin J
    Neuropharmacology; 1979 Nov; 18(11):845-9. PubMed ID: 551318
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta.
    Giustizieri M; Bernardi G; Mercuri NB; Berretta N
    J Neurophysiol; 2005 Sep; 94(3):1992-2003. PubMed ID: 15944237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential action of dopamine agonists on brain self-stimulation behaviour in rats.
    Wauquier A
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):325-8. PubMed ID: 747483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.